Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2008
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1370572B1 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
11/26/2008EP1365763B1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
11/26/2008EP1328267B1 Method of treating cancer using dithiocarbamate derivatives
11/26/2008EP1299110B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and antimetabolites
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008CN101312746A Preparation containing iron(iii)-complexes and redox substances
11/26/2008CN101312745A Therapeutic agent for skin or skin repair-promoting agent comprising ghrelin, derivative thereof or substance capable of acting on ghs-r1a as active ingredient
11/26/2008CN101312741A Chemo-immunotherapy method
11/26/2008CN101312732A Method of preventing oral staining
11/26/2008CN101312731A Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
11/26/2008CN101310772A Nitric oxide donors for inducing neurogenesis
11/26/2008CN101310771A Visual function disorder improving agents
11/26/2008CN101310724A Uses of adenosine a2alpha receptor antagonists
11/26/2008CN101310723A Use of compounds that are effective as selective opiate receptor modulators
11/26/2008CN101310719A Combination chemotherapy
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436470C Polynucleotide for identifying polypeptide OT10 and coding OT10 of tumor cell and uses thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436420C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
11/26/2008CN100435844C Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
11/26/2008CN100435793C Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
11/26/2008CN100435785C Methods and compounds for inhibiting amyloid deposits
11/25/2008US7456220 Immunodulatory compositions and methods of use thereof
11/25/2008US7456198 Useful in the treatment of chronic and acute pain.
11/25/2008US7456159 For delivering therapeutically effective amount of a drug that includes a parent drug and a prodrug; for delivering steroids
11/25/2008US7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
11/25/2008US7456146 Anticarcinogenic agents for use in the treatment of cancer
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455964 Genes from the 20q13 amplicon and their uses
11/25/2008US7455846 Immune potentiating compositions of cancer cells
11/25/2008US7455843 useful for enhancing immune response to antigens; vaccines; applicable to mucosal immunization in humans
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/25/2008CA2348390C Compositions for the treatment and prevention of neurological and pathopsychological diseases
11/25/2008CA2306508C Production of a directly compressible tabletting aid
11/25/2008CA2276606C Method of treating prostatic diseases using active vitamin d analogues
11/25/2008CA2264776C Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/20/2008WO2008140051A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/20/2008WO2008139947A1 Prophylactic or therapeutic agent for diarrhea
11/20/2008WO2008139804A1 Low-molecule drug-containing nanoparticle having sustained release negatively charged group
11/20/2008WO2008139703A1 Agent for treatment of pulmonary disease
11/20/2008WO2008138646A1 Low-viscous anthracycline formulation
11/20/2008WO2008116195A3 Compositions comprising an sglt2 ingibitor for treating obesity
11/20/2008WO2008080092A3 Compositions comprising bile acid sequestrants for treating esophageal disorders
11/20/2008WO2008045641A3 Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent
11/20/2008WO2008033299A3 Use of n-containing spirocompounds for the enhancement of cognitive function
11/20/2008WO2008031817A3 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors
11/20/2008WO2008006118A3 Novel regimens for treating diseases and disorders
11/20/2008WO2008006117A3 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures
11/20/2008WO2008006052A3 Bicyclic heteroaryl inhibitors of pde4
11/20/2008WO2007094999A3 Ungual antifungal compositions
11/20/2008WO2003061577A8 Polyalkylene glycol with moiety for conjugating biologically active compound
11/20/2008US20080288085 Vivo synthesis of connective tissues
11/20/2008US20080287501 Therapeutic uses of an insulin secretion enhancer
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287470 Presentation of an Antiviral Pharmaceutical Composition
11/20/2008US20080287467 Therapeutic Agent for Respiratory Diseases
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287403 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080287389 Nucleoside analogs in combination therapy of herpes simplex infections
11/20/2008US20080287357 Conjugate Comprising P21 Protein for the Treatment of Cancer
11/20/2008US20080287353 Peptides and proteins for early liver development and antibodies thereto
11/20/2008US20080287347 Novel Lipopeptides as Antibacterial Agents
11/20/2008US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof
11/20/2008US20080286789 Genomic polymorphism for predicting therapeutic response
11/20/2008US20080286781 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/20/2008US20080286354 administering a bile acid e.g ursodiol, ursodiol bicarbonate and ursodiol sulfate, a fibrate e.g. bezafibrate, fenofibrate, gemfibrozil, ciprofibrate and derivatives of 2-phenoxy-2-methylpropanoic acid, and a statin e.g. simvastatin, fluvastatin, pravastatin, atorvastatin to treat chronic hepatitis
11/20/2008US20080286339 Using multi-segment device to deliver selective androgen and estrogen receptor modulators to women in order to relieve symptoms associated with menopause
11/20/2008US20080286322 Methods and devices for the sustained release of multiple drugs
11/20/2008US20080286321 Polymer No Donor Predrug Nanofiber Coating for Medical Devices and Therapy
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286261 Methods of modulating hair growth
11/20/2008US20080286255 Treatment for eye disorder
11/20/2008US20080286254 Composition comprising licorice polyphenol
11/20/2008US20080286232 Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
11/20/2008US20080286212 Antimicrobial Formulations and Methods of Using the Same
11/20/2008CA2687291A1 Low-viscous anthracycline formulation
11/20/2008CA2686394A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/20/2008CA2685054A1 Agent for treatment of pulmonary disease
11/19/2008EP1992361A1 Remedy or preventive for digestive ulcer
11/19/2008EP1992360A1 Joint use of tgf-beta signal inhibitor and antitumor agent
11/19/2008EP1992359A1 Neurotropic virus transport
11/19/2008EP1992355A1 Pharmaceutical combination medication comprising NSAIDs or cytoxic drugs
11/19/2008EP1992348A1 Pharmaceutical combination
11/19/2008EP1992343A1 Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
11/19/2008EP1992337A1 Novel modified release composition and use
11/19/2008EP1992335A1 Spray drying methods and compositions thereof
11/19/2008EP1992333A1 Flurbiprofen and muscle relaxant combinations
11/19/2008EP1992317A2 Devices for intraocular drug delivery
11/19/2008EP1991269A1 Compounds and methods for treatment of stroke
11/19/2008EP1991232A1 Combinations of steroids and methylxanthine compounds
11/19/2008EP1991213A2 Anti-mycobacterial formulation comprising octanesulphonylacetamide (osa), nonanesulphonylacetamide (nsa) and decanesulphonylacetamide (dsa)
11/19/2008EP1677806B1 Methods for treating acute and overuse sprain and strain using hyaluronic acid
11/19/2008EP1613288B1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
11/19/2008EP1509232B1 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 1151